gentian violet and Bone Loss, Osteoclastic

gentian violet has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Vikulina, T; Weitzmann, MN; Yamaguchi, M	1

Other Studies

1 other study(ies) available for gentian violet and Bone Loss, Osteoclastic

Article	Year
Gentian violet inhibits MDA-MB-231 human breast cancer cell proliferation, and reverses the stimulation of osteoclastogenesis and suppression of osteoblast activity induced by cancer cells. Oncology reports, 2015, Volume: 34, Issue:4 Topics: Animals; Bone Marrow Cells; Bone Resorption; Breast Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Coculture Techniques; Female; Gentian Violet; Humans; Mice; Osteoblasts; Osteoclasts; Xenograft Model Antitumor Assays	2015

Article

Year

Gentian violet inhibits MDA-MB-231 human breast cancer cell proliferation, and reverses the stimulation of osteoclastogenesis and suppression of osteoblast activity induced by cancer cells.

Oncology reports, 2015, Volume: 34, Issue:4

Topics: Animals; Bone Marrow Cells; Bone Resorption; Breast Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Coculture Techniques; Female; Gentian Violet; Humans; Mice; Osteoblasts; Osteoclasts; Xenograft Model Antitumor Assays

2015